Stocks and Investing Stocks and Investing
Fri, June 26, 2020
Thu, June 25, 2020

David Lewis Maintained (ABT) at Buy with Decreased Target to $100 on, Jun 25th, 2020


Published on 2024-10-27 08:43:13 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $108 to $100 on, Jun 25th, 2020.

David has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Decreased Target to $93 on, Wednesday, April 8th, 2020


These are the ratings of the 9 analyists that currently disagree with David


  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $102 on, Friday, April 17th, 2020
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $109 on, Friday, April 17th, 2020
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $107 on, Friday, April 17th, 2020
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $106 on, Friday, April 17th, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Friday, April 17th, 2020
  • Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $113 on, Friday, April 17th, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $108 on, Friday, April 17th, 2020
  • Kevin Huang of "CFRA" Maintained at Strong Buy with Increased Target to $101 on, Thursday, April 16th, 2020
  • Joanna Wiensch of "Citigroup" Initiated at Strong Buy and Held Target at $96 on, Thursday, March 5th, 2020
Contributing Sources